Vise Technologies’s Clover Health Investments CLOV Stock Holding History

Vise Technologies’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$115K	Buy	+26,654	New	+$119K	﹤0.01%	2037

Other funds holding CLOV

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Turtle Creek Wealth Advisors Dallas, Texas $1.98B AUM 28.66% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

SeaCrest Wealth Management Purchase, New York $883M AUM 33.97% 1-Year Est. Return

Silverleafe Capital Partners Germantown, Tennessee $351M AUM 24.63% 1-Year Est. Return

VCM

Viewpoint Capital Management Seattle, Washington $214M AUM 18.61% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Vise Technologies's CLOV Position: Q3 2026 in Review

Vise Technologies opened a new position in Clover Health Investments (CLOV) in Q3 2026: 26,654 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #2037 among its holdings.

44 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

Vise Technologies held 26,654 shares of Clover Health Investments worth $115K as of Q3 2026.
Clover Health Investments was a new Vise Technologies position in Q3 2026.
Clover Health Investments made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #2037 holding.
44 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.